Pell Bio-Med Technology Co., Ltd. (6949)
Market Closed
15 Jun, 05:30
TWSE TWSE Primary NT$
740. 00
+23
+3.2078%
NT$
36.78B Market Cap
- P/E Ratio
- Div Yield
341,509 Volume
- Eps
NT$ 717
Previous Close Want to track 6949 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pell Bio-Med Technology Co., Ltd. (6949) Statistics
Valuation metrics
Market Cap 36.78B
Enterprise value 44.98B
Trailing P/E (ttm) -103.27
Forward P/E -
PEG ratio 11.43
Price/Sales (ttm) 1,818.02
Price/Book (mrq) 17.49
Enterprise Value/Revenue 1,740.29
Enterprise Value/EBITDA -101.21
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 181.99K
Average volume (90 days) 197.51K
Price summary
52-Week low 127
52-Week high 929
Beta -
50-Day moving average 698.23
200-Day moving average 564.09
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -17.43%
Operating margin -18.23%
Operational effectiveness
Return on assets -0.14%
Return on equity -0.3%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.4
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.94
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 37.74
Total debt (mrq) -
Total Debt/Equity (mrq) 0.09
Current ratio (mrq) 9.6%
Book value per share (mrq) 45.02
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
